Kayentis, a global leader in eCOA and Decentralized Clinical Trial solutions, empowers pharma, biotech, and CROs to streamline data collection in clinical trials, enhancing simplicity, efficiency, and data quality. Since 2005, Kayentis has spearheaded clinical development, specializing in eCOA solutions across phases I-IV in diverse therapeutic areas. Adapting to the changing landscape, Kayentis now offers a comprehensive suite of services to support the shift towards decentralized and hybrid trials, with operational capabilities across the USA, Europe, and Asia.
Web: https://kayentis.com
Email: sales@kayentis.com